Novonesis (Novozymes) B (OTCPK:NVZMY)
$ 62.43 -0.16 (-0.26%) Market Cap: 28.99 Bil Enterprise Value: 30.86 Bil PE Ratio: 39.64 PB Ratio: 2.43 GF Score: 97/100

Q1 2020 Novozymes A/S Organic Sales Call Transcript

Apr 07, 2020 / 10:00AM GMT
Release Date Price: $46.75 (+4.43%)
Operator

Ladies and gentlemen, welcome to the Novozymes conference call. (Operator Instructions). Just to remind you, this call is being recorded. I will start by handing over to Tobias Bjorklund, Head of Investor Relations. Please begin your meeting.

Tobias Cornelius Bjorklund;S;Head of IR
Novozymes A

/-

Thank you, operator. And thank you all for calling in with such a relatively short notice. From Novozymes, I'm joined by the entire management team as well as the Investor Relations team. And the purpose of today's call is to answer any immediate questions following the announcement released this morning. We expect the call to last around 30 minutes. Due to the current circumstances, we have a virtual internal and external setup to enable this call. This is, of course, a new way for all of us to run these meetings as we are placed in different locations. I hope we can execute the call without any technical difficulties. On today's call, CEO, Ester Baiget, will begin by providing comments; followed by CFO, Lars Green, who will speak to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot